Physician profile
John Edward Keyser
NPI 1336146042
$247.09
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $31.09 · 2021: $30.45 · 2022: $15.96.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $63.12 | 2019 | |
| Boston Scientific Corporation | $47.49 | 2020-2022 | |
| Musculoskeletal Transplant Foundation INC. | $40.28 | 2019 | |
| Medtronic Vascular, INC. | $35.78 | 2019-2020 | |
| Allergan, INC. | $32.04 | 2019 | |
| Biocompatibles, INC. | $16.53 | 2019 | |
| Tactile Systems Technology INC | $11.85 | 2021 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Keyser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.